Product Content Compliance in Pharma E-Commerce

Compliance guide for regulatory, legal and content teams in CHC pharma and health & beauty in the UK

Introduction: Online Product Content, a Regulatory Minefield

Selling health products online in the UK is not like selling trainers or electronics. Every product page, every promotional banner, every food supplement description published on an e-commerce site is subject to one of the strictest regulatory frameworks in Europe. And the consequences of a misstep don't stop at a fine: they can include product recalls, public enforcement notices and lasting damage to brand reputation.

The UK health e-commerce market is experiencing significant growth. Online sales of over-the-counter medicines, food supplements, health and beauty products and medical devices have seen sustained growth in recent years, accelerated by the health crisis and digital shopping habits that have become entrenched since. Licensed online pharmacies and platforms like Boots.com, Superdrug.com and LloydsPharmacy attract millions of consumers each month.

But this growth comes with increased regulatory scrutiny. The MHRA (Medicines and Healthcare products Regulatory Agency), the CMA (Competition and Markets Authority), the ASA (Advertising Standards Authority) and local health authorities form an oversight ecosystem that leaves virtually no grey areas. Unlike the United States or some other markets, where brands have greater latitude in online product communication, the UK imposes a materially more restrictive framework where every word counts.

This guide aims to provide regulatory, legal and content teams with a comprehensive operational framework for navigating these rules. It covers the four regulatory pillars that affect digital content for health products, the most frequent violations on digital shelves and their consequences, building a review and approval process adapted to e-commerce, and the boundary between what can be automated and what requires human examination.